<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="403">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05155904</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_204</org_study_id>
    <nct_id>NCT05155904</nct_id>
  </id_info>
  <brief_title>Outcomes of Veno Arterial ECMO</brief_title>
  <acronym>ECMOCARD</acronym>
  <official_title>In-hospital Mortality of Patients With Veno Arterial ECMO: a Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      veno arterial (VA) extra corporeal membrane oxygenation (ECMO) is a rescue therapy with&#xD;
      various indications including refractory cardiac arrest and refractory cardiogenic shock.&#xD;
      Amiens hospital university has an ECMO program and is a regional center to address patients&#xD;
      requiring VA ECMO. In spite of the application of international guidelines, the mortality of&#xD;
      patients with VA remains high with an admitted survival rate at hospital discharge at 40%.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2021</start_date>
  <completion_date type="Anticipated">November 2026</completion_date>
  <primary_completion_date type="Anticipated">November 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>Up to hospital discharge, an average of 1 month</time_frame>
    <description>In-hospital mortality of patients with : veno arterial (VA) extra corporeal membrane oxygenation (ECMO)</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Mortality</condition>
  <condition>Extra Corporeal Membrane Oxygenation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted in Amiens hospital university beneficing of a veno arterial (VA) extra&#xD;
        corporeal membrane oxygenation (ECMO).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age : â‰¥ 18&#xD;
&#xD;
          -  Patient with a VA ECMO&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age&lt;18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Osama Abou Arab, MD</last_name>
    <phone>03 22 08 78 36</phone>
    <email>abouarab.osama@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama ABOU ARAB</last_name>
      <email>abouarab.osama@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 16, 2021</study_first_submitted>
  <study_first_submitted_qc>December 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2021</study_first_posted>
  <last_update_submitted>December 13, 2021</last_update_submitted>
  <last_update_submitted_qc>December 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>veno arterial</keyword>
  <keyword>mortality</keyword>
  <keyword>extra corporeal membrane oxygenation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

